Search Results - "puente, angela"

Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension by Lens, Sabela, Baiges, Anna, Alvarado-Tapias, Edilmar, LLop, Elba, Martinez, Javier, Fortea, Jose Ignacio, Ibáñez-Samaniego, Luís, Mariño, Zoe, Rodríguez-Tajes, Sergio, Gallego, Adolfo, Bañares, Rafael, Puente, Ángela, Albillos, Agustín, Calleja, Jose Luis, Torras, Xavier, Hernández-Gea, Virginia, Bosch, Jaume, Villanueva, Cándid, García-Pagán, Juan Carlos, Forns, Xavier

“…Clinically significant portal hypertension (CSPH), defined as a hepatic venous pressure gradient (HVPG) ≥10 mmHg, persists 24 weeks after sustained virological…”
Get full text

Non-invasive tests for clinically significant portal hypertension after HCV cure by Semmler, Georg, Lens, Sabela, Meyer, Elias L., Baiges, Anna, Alvardo-Tapias, Edilmar, Llop, Elba, Tellez, Luis, Schwabl, Philipp, Mauro, Ezequiel, Escudé, Laia, Díez, Cristina, Ibañez-Samaniego, Luis, Puente, Ángela, Fortea, José Ignacio, Abadía, Marta, Zanetto, Alberto, Conthe, Andrés, Hernandez-Évole, Helena, Luzko Scheid, Irina Sofia, Jia, Jidong, Yoshiji, Hitoshi, Francque, Sven M., Tsochatzis, Emmanuel A., Russo, Francesco Paolo, Crespo, Gonzalo, Forns, Xavier, Bañares, Rafael, Villanueva, Càndid, Hernández-Gea, Virginia, Reiberger, Thomas, Bosch, Jaume, García Pagán, Juan Carlos, Mandorfer, Mattias

“…Non-invasive tests (NITs) for clinically significant portal hypertension (CSPH; hepatic venous pressure gradient [HVPG] ≥10 mmHg) have predominantly been…”
Get full text

A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis by Villanueva, Càndid, Graupera, Isabel, Aracil, Carles, Alvarado, Edilmar, Miñana, Josep, Puente, Ángela, Hernandez‐Gea, Virginia, Ardevol, Alba, Pavel, Oana, Colomo, Alan, Concepción, Mar, Poca, María, Torras, Xavier, Reñe, Josep M., Guarner, Carlos

“…Monitoring the hemodynamic response of portal pressure (PP) to drug therapy accurately stratifies the risk of variceal rebleeding (VRB). We assessed whether…”
Get full text

LOXL2-A New Target in Antifibrogenic Therapy? by Puente, Angela, Fortea, Jose Ignacio, Cabezas, Joaquin, Arias Loste, Maria Teresa, Iruzubieta, Paula, Llerena, Susana, Huelin, Patricia, Fábrega, Emilio, Crespo, Javier

“…The concept of liver fibrosis and cirrhosis being static and therefore irreversible is outdated. Indeed, both human and animal studies have shown that…”
Get full text

Impact of anticoagulation on upper‐gastrointestinal bleeding in cirrhosis. A retrospective multicenter study by Cerini, Federica, Gonzalez, Javier Martínez, Torres, Ferran, Puente, Ángela, Casas, Meritxell, Vinaixa, Carmen, Berenguer, Marina, Ardevol, Alba, Augustin, Salvador, Llop, Elba, Senosiaín, Maria, Villanueva, Càndid, de la Peña, Joaquin, Bañares, Rafael, Genescá, Joan, Sopeña, Júlia, Albillos, Agustín, Bosch, Jaume, Hernández‐Gea, Virginia, Garcia‐Pagán, Juan Carlos

“…Recent studies have shown that liver cirrhosis (LC) behaves as an acquired hypercoagulable state with increased thrombotic risk. This is why anticoagulation…”
Get full text

Number of Antibody-verified Eplet in HLA-C Locus as an Independent Factor of T-cell–Mediated Rejection After Liver Transplantation by Guiral, Sandra, Segundo, David San, Irure, Juan, Casafont, Fernando, Fortea, Jose Ignacio, Puente, Ángela, López-Hoyos, Marcos, Crespo, Javier, Fabrega, Emilio

“…BACKGROUND.HLA mismatching is a risk factor for graft rejection in solid organ transplantation. Its definition is being rethought with the introduction of the…”
Get full text

SARS-CoV-2 and Liver Transplant: How Has It Behaved in This Sixth Wave? by Odriozola, Aitor, San Segundo, David, Cuadrado, Antonio, Hernáez, Tania, Escrich, Víctor, Fortea, José Ignacio, Martínez, Ángela, Puente, Ángela, Lapeña, Berta, del Barrio, María, López-Hoyos, Marcos, Crespo, Javier, Fábrega, Emilio

“…Since the declaration of a new variant of concern (VOC), Omicron, by the World Health Organization in November 2021, a quick spread has been documented…”
Get full text

High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic‐associated fatty liver disease by Odriozola, Aitor, Puente, Ángela, Cuadrado, Antonio, Iruzubieta, Paula, Arias‐Loste, María T., Redondo, Carlos, Rivas, Coral, Fábrega, Emilio, Crespo, Javier, Fortea, José I.

“…Background and Aims Spleen stiffness measurement (SSM) by vibration‐controlled transient elastography (VCTE) has been tested in a limited number of studies…”
Get full text

Protective measures against Omicron could be more effective than cilgavimab/tixagevimab in liver transplant recipients by Herran, Aitor Odriozola, Ormaechea, Jose Ignacio Fortea, Lavin, Antonio Cuadrado, Sanchez, Angela Puente, Lazarus, Jeffrey, Crespo, Javier, Fabrega, Emilio

Get full text

CD64 expression on neutrophils as a potential biomarker for bacterial infection in ascitic fluid of cirrhotic patients by González-López, Elena, Odriozola Herrán, Aitor, Renuncio García, Mónica, Roa-Bautista, Adriel, Antón Rodríguez, Ángela, Comins-Boo, Alejandra, Irure Ventura, Juan, Puente, Ángela, López-Hoyos, Marcos, Fortea, José Igancio, San Segundo, David

“…CD64 expression on neutrophils surface (CD64N) by flow cytometry has been validated as a rapid biomarker for bacterial infections in both peripheral blood and…”
Get full text

Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review by Odriozola, Aitor, Puente, Ángela, Cuadrado, Antonio, Rivas, Coral, Anton, Ángela, González, Francisco José, Pellón, Raúl, Fábrega, Emilio, Crespo, Javier, Fortea, José Ignacio

“…Portal vein thrombosis constitutes the most common thrombotic event in patients with cirrhosis, with increased rates in the setting of advanced liver disease…”
Get full text

Ectopic variceal bleeding secondary to porto-sinusoidal vascular disease by Antón RodrÍguez, Ángela, Puente Sánchez, Ángela María, Fortea, José Ignacio, Odriozola Herrán, Aitor, Echavarría Rodríguez, Víctor José, Alonso Fernández, Sara, Montano Lumbreras, Elena

“…Porto-sinusoidal vascular disease (PSVD) is an uncommon cause of portal hypertension (PHT) characterized by typical manifestations of PHT in the absence of an…”
Get full text

Management of haemostatic alterations and associated disorders in cirrhosis in Spain: A national survey by Fortea, José Ignacio, Puente, Ángela, Ezcurra, Iranzu, Cuadrado, Antonio, Arias-Loste, María Teresa, Cabezas, Joaquín, Llerena, Susana, Iruzubieta, Paula, Rodríguez-Lope, Carlos, Huelin, Patricia, Casafont, Fernando, Fábrega, Emilio, Crespo, Javier

“…Knowledge of haematological abnormalities in cirrhosis has greatly improved in recent years. To evaluate how Spanish Digestive Disease specialists manage…”
Get full text

Non‐malignant portal vein thrombosis in a cohort of cirrhotic patients: Incidence and risk factors by Lopez‐Gomez, Marta, Llop, Elba, Puente, Angela, Hernández Conde, Marta, Ruiz, Patricia, Alvárez, Silvia, Martínez, Jose Luis, Abad, Javier, Fernández, Natalia, Perelló, Christie, Fernández‐Carrillo, Carlos, Ferre, Carlos, Trapero, Maria, Fraga, Enrique, Crespo, Javier, Calleja Panero, Jose Luis

“…Aim Non‐malignant portal vein thrombosis (PVT) is a complication of liver cirrhosis. The aim of this study was to evaluate the annual incidence of PVT and…”
Get full text

Risk of Recurrence of Hepatocarcinoma after Liver Transplantation: Performance of Recurrence Predictive Models in a Cohort of Transplant Patients by Cuadrado, Antonio, Fortea, José Ignacio, Rodríguez-Lope, Carlos, Puente, Ángela, Fernández-Vilchez, Vanesa, Echavarria, Victor Jose, Castillo Suescun, Federico José, Fernández, Roberto, Echeverri, Juan Andrés, Achalandabaso, Mar, Toledo, Enrique, Pellón, Raúl, Rodríguez Sanjuan, Juan Carlos, Crespo, Javier, Fábrega, Emilio

“…Liver transplantation (LT) is a curative treatment for early-stage hepatocellular carcinoma (HCC) unsuitable for surgical resection. However, tumor recurrence…”
Get full text

No evidence of association between inherited thrombophilia and increased risk of liver fibrosis by Ezcurra, Iranzu, Puente, Ángela, Cuadrado, Antonio, Tamayo, Ibai, Iruzubieta, Paula, Arias‐Loste, María Teresa, González, Francisco José, Pellón, Raúl, Sánchez, Sara, Crespo, Juan, Acebo, Mercedes, López‐Hoyos, Marcos, Pérez, Rocío, Cuesta, Amalia, Antón, Ángela, Echavarría, Víctor, Fábrega, Emilio, Crespo, Javier, Fortea, Jose Ignacio

“…Background Preliminary evidence suggests that inherited hypercoagulable disorders can lead to an increased risk of significant liver fibrosis. Objective We…”
Get full text

Plasma betatrophin levels in patients with liver cirrhosis by Arias-Loste, Maria Teresa, García-Unzueta, Maria Teresa, Llerena, Susana, Iruzubieta, Paula, Puente, Angela, Cabezas, Joaquín, Alonso, Carmen, Cuadrado, Antonio, Amado, José Antonio, Crespo, Javier, Fábrega, Emilio

“…AIM: To investigate the plasma levels of betatrophin in patients with cirrhosis.METHODS: Forty patients diagnosed at the clinic with liver cirrhosis according…”
Get full text

Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseases by García-Nieto, Enrique, Rodriguez-Duque, Juan Carlos, Rivas-Rivas, Coral, Iruzubieta, Paula, Garcia, María José, Rasines, Laura, Alvarez-Cancelo, Ana, García-Blanco, Agustín, Fortea, José Ignacio, Puente, Angela, Castro, Beatriz, Cagigal, Maria Luisa, Rueda-Gotor, Javier, Blanco, Ricardo, Rivero, Montserrat, Armesto, Susana, González-López, Marcos Antonio, Codina, Anna Esteve, Gut, Marta, Vaque, Jose Pedro, Crespo, Javier, Arias-Loste, María Teresa

“…Growing evidence suggests an increased prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in the context of immune-mediated…”
Get full text

Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders by Fortea, José Ignacio, Carrera, Inés García, Puente, Ángela, Cuadrado, Antonio, Huelin, Patricia, Tato, Carmen Álvarez, Fernández, Paloma Álvarez, Montes, María del Rocío Pérez, Céspedes, Javier Nuñez, López, Ana Batlle, Sanchez, Francisco José González, Hoyos, Marcos López, Crespo, Javier, Fábrega, Emilio

“…In patients with liver cirrhosis the contribution of inherited and acquired prothrombotic disorders in the development of non-malignant portal vein thrombosis…”
Get full text

Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver by Martín-Llahí, Marta, Albillos, Agustín, Bañares, Rafael, Berzigotti, Annalisa, García-Criado, M Ángeles, Genescà, Joan, Hernández-Gea, Virginia, Llop-Herrera, Elba, Masnou-Ridaura, Helena, Mateo, José, Navascués, Carmen A, Puente, Ángela, Romero-Gutiérrez, Marta, Simón-Talero, Macarena, Téllez, Luis, Turon, Fanny, Villanueva, Cándido, Zarrabeitia, Roberto, García-Pagán, Juan Carlos

“…Despite their relatively low prevalence, vascular diseases of the liver represent a significant health problem in the field of liver disease. A common…”
Get more information